TeleGraft project brings together researchers and practitioners from eleven partner institutions from Denmark, Sweden, Great Britain, Lithuania, Germany, Spain, and Portugal. Read more about the different partners and their role in the project here.
Responsible for arteriovenous graft function, exploitation, regulatory and ethics compliance of the device with relevant medical and diagnostic regulations.
Responsible for the development of a software that will display the outcomes of AI modelling to the end-user. Additionally, the monitoring dashboard will be enhanced with technical solutions, enabling remote access for patients and offering standard interfaces to external health information systems.
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
Tasked with the integration of an optical sensor and waveguiding system into arteriovenous grafts, converting raw data into comprehensible outcomes using sophisticated AI modeling techniques.
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
Region Syddanmark
Odense University Hospital, a constituent of Region Syddanmark, holds responsibility for the approval of clinical trials and the execution of clinical studies within the Department of Cardiothoracic and Vascular Surgery. Additionally, it oversees matters related to thrombosis and infection within the Department of Clinical Microbiology.
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
Tasked with the role of conducting in vitro evaluations, where all graft components are integrated into a prototype.
University of Southern Denmark
In TeleGraft, 开云体育提现 is the project coordinator, responsible for efficient project management and transparent financial management, communication, and dissemination but also to define the health economy model.
VERIGRAFT AB will develop a biological coating for the adventitial aspect of the graft.
Participating hospital in the clinical trial, representative of End-user board members, which secures regional differences regarding need of evidence and ethical approval. Involved in the second phase of the project.
